In conclusion, the data suggest a possible novel therapeutic approach in sepsis/ARDS by targeting NSF, a trafficking mediator molecule involved in the secretion of inflammatory mediators from endothelial cells and in the maintenance of vascular tone. This evidence concerns the gene NSF and Sepsis.